Back to Agenda
Case Analysis and Inspiration of Negative Results in Clinical Trials of Antitumor Drugs
Session Chair(s)
Shun Lu
Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest Hospital,
Shanghai Jiaotong University, China
The results of phase III RCTs are an important basis for formulating treatment guidelines for patients. Although negative test results will bring regrets, those of well-designed clinical studies are of great significance to clinicians and researchers. The session will focus on negative cases of antitumor drug clinical trials, and invite clinical researchers and statisticians to inspire participants from their respective perspectives.
Have an account?